Technical Analysis for NVLN - Novelion Therapeutics Inc.

Grade Last Price % Change Price Change
grade D 0.8 8.47% 0.06
NVLN closed up 8.47 percent on Friday, September 13, 2019, on 3.37 times normal volume.

Earnings due: Sep 27

*** please verify all earnings dates ***

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Up Up
See historical NVLN trend table...

Date Alert Name Type % Chg
MACD Bullish Centerline Cross Bullish 0.00%
Expansion Breakout Bullish Swing Setup 0.00%
Expansion Pivot Buy Setup Bullish Swing Setup 0.00%
Volume Surge Other 0.00%
Wide Range Bar Range Expansion 0.00%
Above Upper BB Strength 0.00%
Up 3 Days in a Row Strength 0.00%
Upper Bollinger Band Touch Strength 0.00%
Crossed Above 20 DMA Bullish 8.47%
Crossed Above 50 DMA Bullish 8.47%

Older signals for NVLN ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Novelion Therapeutics Inc, formerly QLT Inc., is a Canada-based biopharmaceutical company. The Company is engaged in development of new standards of care for individuals living with rare diseases. The Company is focused on advancing its portfolio of rare disease therapies by investing in science and clinical development. The Company holds a portfolio of products through its subsidiary, Aegerion Pharmaceuticals, Inc., a biopharmaceutical company dedicated to the development and commercialization of innovative therapies for patients with debilitating rare diseases. The Company's portfolio of products include MYALEPT and JUXTAPID. The Company is also developing zuretinol acetate for the treatment of inherited retinal disease caused by underlying mutations in RPE65 or LRAT genes.
Biotechnology Biopharmaceutical Life Sciences Pharmaceutical Industry Pharmacy Rare Diseases Retinal Disease Innovative Therapies
Is NVLN a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 1 bullish, 2 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 4.04
52 Week Low 0.6
Average Volume 66,134
200-Day Moving Average 0.9982
50-Day Moving Average 0.6926
20-Day Moving Average 0.6788
10-Day Moving Average 0.6698
Average True Range 0.0688
ADX 21.58
+DI 32.7825
-DI 12.9924
Chandelier Exit (Long, 3 ATRs ) 0.6907
Chandelier Exit (Short, 3 ATRs ) 0.8064
Upper Bollinger Band 0.7657
Lower Bollinger Band 0.5919
Percent B (%b) 1.2
BandWidth 25.604007
MACD Line 0.0011
MACD Signal Line -0.0126
MACD Histogram 0.0137
Fundamentals Value
Market Cap 14.92 Million
Num Shares 18.6 Million
EPS -5.12
Price-to-Earnings (P/E) Ratio -0.16
Price-to-Sales 1.11
Price-to-Book 1.08
PEG Ratio 0.13
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 1.04
Resistance 3 (R3) 1.05 0.97 1.00
Resistance 2 (R2) 0.97 0.91 0.97 0.99
Resistance 1 (R1) 0.89 0.87 0.93 0.88 0.97
Pivot Point 0.81 0.81 0.83 0.81 0.81
Support 1 (S1) 0.72 0.75 0.77 0.72 0.63
Support 2 (S2) 0.65 0.71 0.65 0.61
Support 3 (S3) 0.56 0.65 0.60
Support 4 (S4) 0.56